OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer Based on Functional Assessment and NIRS Analysis
Noelia Durán-Gómez, Casimiro Fermín López-Jurado, Marta Nadal-Delgado, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2363-2363
Open Access | Times Cited: 16

Showing 16 citing articles:

Brain correlates of subjective cognitive complaints in COVID-19 survivors: A multimodal magnetic resonance imaging study
Marco Paolini, Mariagrazia Palladini, Mario Gennaro Mazza, et al.
European Neuropsychopharmacology (2022) Vol. 68, pp. 1-10
Open Access | Times Cited: 38

Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer
Senbang Yao, Qianqian Zhang, Xinxin Yao, et al.
Breast Cancer Research and Treatment (2023) Vol. 201, Iss. 1, pp. 15-26
Closed Access | Times Cited: 13

Self-Reported Cognitive Function in Older Breast Cancer Survivors after Chemotherapy Treatment
Rachel Kim, Julia Peña, Kaiping Liao, et al.
The Breast (2025) Vol. 81, pp. 104468-104468
Open Access

Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors
Xuan Zhou, Xueyan Zhang, Tangsheng Zhong, et al.
Journal of Advanced Nursing (2023) Vol. 80, Iss. 2, pp. 484-499
Closed Access | Times Cited: 12

Psychological distress is involved in CRCI in breast cancer survivors via mediating cytokine levels
Lulian Pang, Wen Li, Senbang Yao, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11806-11815
Open Access | Times Cited: 11

Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment
Zhimeng Yao, Hongmei Dong, Jianlin Zhu, et al.
JCI Insight (2023) Vol. 8, Iss. 14
Open Access | Times Cited: 10

Prevalence of Psychoneurological Symptoms and Symptom Clusters in Women with Breast Cancer Undergoing Treatment: Influence on Quality of Life
Noelia Durán-Gómez, Casimiro Fermín López-Jurado, Marta Nadal-Delgado, et al.
Seminars in Oncology Nursing (2023) Vol. 39, Iss. 4, pp. 151451-151451
Open Access | Times Cited: 4

Functional Imaging of Chemobrain: Usefulness of Nuclear Medicine in the Fog Coming After Cancer
Agostino Chiaravalloti, Luca Filippi, Marco Pagani, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 4, pp. 508-514
Open Access | Times Cited: 3

Changes in cognition and neuroinflammation in a rodent model of chemotherapy-induced cognitive impairment are variable both acutely and chronically
Olivia J. Haller, Ines Semendric, Lyndsey E. Collins‐Praino, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer
Hyo S. Han, Amy L. Aldrich, Saurabh Garg, et al.
JAMA Oncology (2024)
Closed Access

Changes in cognition and astrocytic reactivity in a female rodent model of chemotherapy-induced cognitive impairment are variable both acutely and chronically
Olivia J. Haller, Ines Semendric, Lyndsey E. Collins‐Praino, et al.
Behavioural Brain Research (2024) Vol. 480, pp. 115391-115391
Open Access

Page 1

Scroll to top